Shionogi's Osphena, or ospemifene, has been approved by the FDA to treat dyspareunia, a condition characterized by pain during sex, in postmenopausal women. The drug gives patients another option for treatment, FDA Office of Drug Evaluation Deputy Director Victoria Kusiak said.
FDA OKs drug for pain during sex for postmenopausal women
SmartBrief Job Listings for Health Care
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
Meridian Health Plan